Lateral Flow Disease Testing Market to Achieve USD 6.8 Billion by 2020 Owing to Increased Drug Resistant Pathogens
Lateral Flow Disease Testing Market – Global Diagnostic Applications and End Users Analysis and Forecast 2013-2020
Maryland Heights, MO, June 22, 2016 --(PR.com)-- According to a market research report published by iHealthcareAnalyst, Inc., Lateral Flow Disease Testing Market – Global Diagnostic Applications and End Users Analysis and Forecast 2013-2020, the global lateral flow disease testing market was valued at USD 5.1 Billion in 2015 and is estimated to reach USD 6.8 Billion by 2020, at a CAGR of 5.8% from 2016 to 2020.
Browse the Lateral Flow Disease Testing Market – Global Diagnostic Applications and End Users Analysis and Forecast 2013-2020 at http://www.ihealthcareanalyst.com/report/lateral-flow-diagnostic-testing-market/
Lateral flow tests or immunochromatographic assays are conducted using simple devices in order to detect the presence (or absence) of a target analyte in a sample (matrix) without the need for specialized and costly equipment. Typically, these tests are used for medical diagnostics either for home testing, point of care testing, or laboratory use. The lateral flow disease testing market report estimates the market size (Revenue USD million - 2013 to 2020) for market segmentation based on disease test (hepatitis, HIV, influenza, malaria, pregnancy, syphilis, etc.), and forecasts growth trends (CAGR% - 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
The global lateral flow disease testing market is segmented as:
1. Application (Test Type)
1.1. Hepatitis
1.2. HIV
1.3. Influenza
1.4. Malaria
1.5. Pregnancy
1.6. Syphilis
1.7. Others
2. End User
2.1. Home Testing
2.2. Point of Care (POC) Testing
2.3. Laboratory Testing
2.4. Others
3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World
4. Company Profiles
4.1. Alere, Inc.,
4.2. Beckman Coulter, Inc.
4.3. Becton, Dickinson and Company
4.4. bioMérieux SA
4.5. Bio-Rad Laboratories
4.6. EMD Millipore
4.7. F. Hoffmann-La Roche Ltd.
4.8. Qiagen
4.9. Siemens Healthcare
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com
Browse the Lateral Flow Disease Testing Market – Global Diagnostic Applications and End Users Analysis and Forecast 2013-2020 at http://www.ihealthcareanalyst.com/report/lateral-flow-diagnostic-testing-market/
Lateral flow tests or immunochromatographic assays are conducted using simple devices in order to detect the presence (or absence) of a target analyte in a sample (matrix) without the need for specialized and costly equipment. Typically, these tests are used for medical diagnostics either for home testing, point of care testing, or laboratory use. The lateral flow disease testing market report estimates the market size (Revenue USD million - 2013 to 2020) for market segmentation based on disease test (hepatitis, HIV, influenza, malaria, pregnancy, syphilis, etc.), and forecasts growth trends (CAGR% - 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
The global lateral flow disease testing market is segmented as:
1. Application (Test Type)
1.1. Hepatitis
1.2. HIV
1.3. Influenza
1.4. Malaria
1.5. Pregnancy
1.6. Syphilis
1.7. Others
2. End User
2.1. Home Testing
2.2. Point of Care (POC) Testing
2.3. Laboratory Testing
2.4. Others
3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World
4. Company Profiles
4.1. Alere, Inc.,
4.2. Beckman Coulter, Inc.
4.3. Becton, Dickinson and Company
4.4. bioMérieux SA
4.5. Bio-Rad Laboratories
4.6. EMD Millipore
4.7. F. Hoffmann-La Roche Ltd.
4.8. Qiagen
4.9. Siemens Healthcare
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Contact
Categories